International Corruption Uncovered: Fresenius Will Pay $231M To Settle Charges Of Bribery, Sloppy Bookkeeping

Fresenius Medical Care has agreed to pay $231m to resolve reports of overseas bribery. The US Department of Justice says the dialysis giant paid bribes to health and government officials in Angola and Saudi Arabia, and failed to keep accurate financial records in Angola, Saudi Arabia, Morocco, Spain, Turkey, and several countries in West Africa.

Businessmen making handshake with money in hands - bribery, corruption and venality concepts - Image

Dialysis giant Fresenius SE & Co. KGaA is paying $231m to resolve reports the company bribed government and health-care officials in Angola and Saudi Arabia and engaged in sloppy bookkeeping in a range of other countries, an agreement recently filed with the US Securities & Exchange Commission shows.

The settlement concludes investigations by the US Department of Justice and the Securities & Exchange Commission into potential violations of...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Compliance

MI-PolicyAndRegulation (Free-1): Biliary Atresia Linked to Autism and Neurodevelopment Delays

 
• By 

Children with biliary atresia (BA) exhibited neurodevelopmental deficits and increased autism traits, with earlier surgery linked to better general neurodevelopment.

Global Medtech Guidance Tracker: September 2024

 
• By 

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 40 documents have been posted on the tracker since its last update.

Global Medtech Guidance Tracker: September 2024

 
• By 

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 40 documents have been posted on the tracker since its last update.

Updated Notified Body Conduct Code Explains Permitted Structured Dialogue

There is considerable focus at present on how far notified bodies can go in helping position their clients to have as smooth a conformity assessment passage as possible. It is a fine balancing act for all involved, but a new document sheds some useful light.

More from Policy & Regulation

News We’re Watching: New FDA Approvals For Breast Implant, Colon Cancer Test, Imaging Agent; TAP Expansion, AI Standards

This week, Establishment Labs Holdings announced the FDA gave it premarket approval for Motiva breast implant, Cologuard lands FDA approval for Cologuard Plus and GE HealthCare gets FDA nod for a new imaging agent. The FDA announces another expansion for TAP into ophthalmology and radiology. The AAMI and CTA will join forces to develop standards for AI and ML-enabled health care products.  

MI-PolicyAndRegulation (Free-1): Biliary Atresia Linked to Autism and Neurodevelopment Delays

 
• By 

Children with biliary atresia (BA) exhibited neurodevelopmental deficits and increased autism traits, with earlier surgery linked to better general neurodevelopment.

Sponsored By

Nancy Tests SPARC-931 Part 7

This is a description